Bank of New York Mellon
FEED

Bank of New York Mellon’s ENvue Medical Inc FEED Stock Holding History

Bank of New York Mellon’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15
Closed -$69K – 4652
2021
Q3 		$69K Buy
+15
New +$66.5K ﹤0.01% 4388

Other funds holding FEED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFS
Amtrust Financial Services New York $336M AUM 16.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon's FEED Position: Q4 2021 in Review

Bank of New York Mellon sold out of ENvue Medical Inc (FEED) in Q4 2021, closing a stake of 15 shares — an estimated $69K sold.

Bank of New York Mellon first reported a position in FEED in Q3 2021 and held it in 1 quarter. The position peaked at $69K in Q3 2021. 19 funds tracked by Wall St. Rank hold FEED as of Q4 2021.

  • Bank of New York Mellon reported no remaining ENvue Medical Inc position as of Q4 2021 after selling out during the quarter.
  • Bank of New York Mellon sold 15 ENvue Medical Inc shares in Q4 2021, an estimated $69K.
  • Bank of New York Mellon first reported a position in ENvue Medical Inc in Q3 2021 and held it in 1 quarter.
  • Bank of New York Mellon's ENvue Medical Inc position peaked at $69K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q4 2021.

Based on Bank of New York Mellon's 13F filing for Q4 2021, filed 11 Feb 2022.